High-Dose Humanized Anti-Il-2 Receptor Alpha Antibody (Daclizumab) for the Treatment of Active, Non-Infectious Uveitis
Journal of Autoimmunity - United States
doi 10.1016/j.jaut.2008.05.001
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2008
Authors
Publisher
Elsevier BV